Jennifer Bouey

@BoueyHuang on Twitter

Senior Policy Researcher; Tang Chair in China Policy Studies

Off Site Office

Education

Ph.D. in epidemiology, George Washington University; M.P.H. in epidemiology, George Washington University; M.D. in clinical medicine, Peking University

Media Resources

This researcher is available for interviews.

To arrange an interview, contact the RAND Office of Media Relations at (310) 451-6913, or email media@rand.org.

More Experts

Overview

Dr. Jennifer Huang Bouey is a senior policy researcher and the Tang Chair in China Policy Studies at the RAND Corporation. As an epidemiologist who led health studies in the United States, China, and several other countries in the last twenty years, her research portfolio centered on health equity, infectious disease prevention, and global health governance. Dr. Bouey served on multiple study sections at the National Institute of Health, and as scientific reviewer for China Natural Science Foundation, Hong Kong AIDS Council, and Hong Kong Government Research Fund. She also provided technical consultancy to the World Bank, Clinton HIV/AIDS Initiative, the Save the Children Federation, Inc., and China’s National and Provincial Centers for Disease Control. She has testified multiple times in front of various committees of the U.S. Congress on China’s public health-, health care-, and global health- related issues. Her work and opinions have appeared in the New York Times, Financial Times, The Global Times, The Atlantic, BBC World, MSNBC, and Bloomberg TV. Prior to RAND, she served as the Susan Mayor Professor for Health Equity at Georgetown Unviersity Global Health program for many years. Dr. Bouey received her Ph.D. in epidemiology from the George Washington University and her Clinical Medicine (M.D.) degree from the Peking University School of Medicine.

Research Focus

Previous Positions

Susan Mayor Professor in Health Equity, School of Nursing and Health Studies, Georgetown University

Selected Publications

Han J*, Bouey JZ*, Wang L, Mi G, Chen Z, He Y, Viviani T, Zhang F, "PrEP Uptake Preferences Among Men Who Have Sex with Men in China: Results from a National Internet Survey," J International AIDS Soc., 22(2), 2019

Stoto MA, Kang M, Song T, Bouey J, Boyce MR, Katz R, "At the frontier of the global battle against emerging infections: surveillance and management of avian influenza A(H7N9) in Guangdong Province, China," J Glob Health Rep , 3, 2019

Shi LJ, Bouey ZJ, Lin L, "Impact of psychological integration and acculturation on mental health among migrant children in Guangzhou, China," BMJ open, 9(5), 2019

Haw, NJ, Yang J, Li H, Lin D, Wang Z, Bouey ZJ* , "Challenges and value of peer outreach workers in needle and syringe exchange programs: Evidence from an HIV prevention program in Yunnan Province, China.," J Ethn Subst Abuse, 15, 2018

Uretsky E, Bouey J, Katz R, "The Changing Paradigm of Global Health with Chinese Characteristics. Global Health Policy," Health Affairs, 2018

11.Chang RC, Hail-Jares K, Zheng H, He N, Bouey ZJ* , "Mitigating circumstances: a model-based analysis of associations between risk environment and infrequent condom use among Chinese street-based sex workers," PloS One, 13(5), 2018

K. Hail-Jares, S. Choi, L. Duo, Z. Luo, *ZJ Huang, "Occupational and Demographic Factors Associated with Drug Use Among Female Sex Workers at the China-Myanmar Border. ," Journal of Alcohol and Drug Dependency., (161), 2016

Huang ZJ, Zheng C, "Type 2 Diabetes among 6 Asian Ethnic Groups in California: The Nexus of Ethnicity, Gender, and Generational Status," J Health Care Poor Underserved, 26(2), 2015

Languages

Chinese; English

Recent Media Appearances

Interviews: Bloomberg Television; CGTN, China Global Television Network; Global Times; People's Daily Online, China

Commentary

Who Will Benefit from a Successful Chinese COVID-19 Vaccine?
China, one of the world's largest producers of vaccines, could be among the first to produce one for COVID-19. If that happens, then would China be able to produce sufficient doses for domestic use? And which other countries would likely benefit?
Aug 12, 2020 The Hill
Global Challenges to Maintaining a Healthy Workforce During a Pandemic: Views from RAND Experts
As nations across the globe remain in lockdown to curb the spread of the COVID-19 pandemic, questions about the future of employment and workforce productivity emerge. During a recent webinar, RAND experts discussed how to get people back to work and improve productivity post COVID-19.
May 15, 2020
U.S. COVID-19 Cases on the Rise: Q&A with RAND Experts
COVID-19, the disease caused by the new coronavirus, is now in all 50 states. And more and more U.S. cases and deaths are being reported. As orders to close schools and restaurants take effect across America, RAND researchers answer some questions about the crisis.
Mar 18, 2020
Coronavirus Outbreak Intensifies: Q&A with RAND Experts
Cases of the coronavirus have now spread to several dozens of countries, infecting thousands and thousands of people across the globe. With concerns about the disease rising, we asked a group of RAND researchers to answer a wide range of questions about the crisis.
Mar 5, 2020
Is Coronavirus Another SARS?
In 2002, the SARS pandemic infected more than 8,000 people and killed 774. How is the coronavirus outbreak similar? And how is it different?
Jan 28, 2020 The World Post

Publications

Journal Article
Illicit Synthetic Opioid Consumption in Asia and the Pacific: Assessing the Risks of a Potential Outbreak
While many illegally manufactured potent synthetic opioids (IMPSO) are produced in Asia, there is little evidence they have entered markets there. We consider the susceptibility to IMPSO's encroachment in markets in the Asia-Pacific region.
Jan 26, 2021
Journal Article
Barriers and Facilitators of Kangaroo Mother Care Adoption in Five Chinese Hospitals: A Qualitative Study
We provided a comprehensive report on the multi-level KMC barriers and facilitators in China. We recommend policy interventions addressing these barriers and facilitators and increase family and peer support to improve KMC adoption in China.
Nov 12, 2020
Journal Article
Delayed Treatment for People Living with HIV in China, 2004–2016: An Analysis of An Observational Cohort
This study analyzed the late testing and lag time between HIV diagnosis and initiation of antiretroviral treatment from 2004 to 2016 and identified the risk factors for delayed initiation of ART.
Nov 12, 2020
Journal Article
Addressing Impact Evaluation Gaps in Belt and Road Initiative Projects in Africa: The Standard Gauge Railway Project in Kenya as a Proof of Concept
Proposing new directions for evaluation framework development targeting the Belt and Road Initiative projects, using the Standard Gauge Railway project in Kenya as a proof of concept of our proposed evaluation framework.
Oct 7, 2020
Testimony
China's Health System Reform and Global Health Strategy in the Context of COVID-19: Addendum
Document submitted on June 23, 2020, as an addendum to testimony before the U.S.-China Economic and Security Review Commission on May 7, 2020.
Jun 24, 2020
Draft
Demystifying the Belt and Road Initiative: A Clarification of its Key Features, Objectives and Impacts
This report describes the Belt and Road Initiative's common criticisms, defining characteristics, and externalities, and the authors explore implications for policymakers.
May 13, 2020
Journal Article
Psychological Symptoms Among Frontline Healthcare Workers During COVID-19 Outbreak in Wuhan
To examine the psychosocial impact of COVID-19 on frontline healthcare workers in Wuhan, we collected data between February 13-17, 2020 through a smartphone-based survey.
May 12, 2020
Testimony
China's Health System Reform and Global Health Strategy in the Context of COVID-19
Testimony presented before the U.S.-China Economic and Security Review Commission on May 7, 2020.
May 7, 2020
Tool
The Health and Economic Impacts of Nonpharmaceutical Interventions to Address COVID-19: A Decision Support Tool for State and Local Policymakers
There is an urgent need for an assessment of public health interventions to address coronavirus disease 2019 (COVID-19) and determine when to relax them. This document describes the COVID-19 Decision Support Tool, which is designed to fill that need.
May 4, 2020
Journal Article
Public Mental Health Crisis During COVID-19 Pandemic, China
Public mental health interventions should be formally integrated into public health preparedness and emergency response plans.
Apr 3, 2020
Journal Article
Strengthening China's Public Health Response System: From SARS to COVID-19
A commentary on China's attempts to strengthen its public health system between the initial Coronavirus outbreak and the subsequent recurrence.
Apr 3, 2020
Testimony
From SARS to 2019-Coronavirus (nCoV): U.S.-China Collaborations on Pandemic Response: Addendum
Document submitted March 5, 2020, as an addendum to testimony before the House Foreign Affairs Subcommittee on Asia, the Pacific, and Nonproliferation on February 5, 2020.
Mar 16, 2020
Testimony
Assessment of COVID-19's Impact on Small and Medium-Sized Enterprises: Implications from China
Testimony presented before the House Small Business Committee on March 10, 2020.
Mar 10, 2020
Testimony
From SARS to 2019-Coronavirus (nCoV): U.S.-China Collaborations on Pandemic Response
Testimony presented before the House Foreign Affairs Subcommittee on Asia, the Pacific, and Nonproliferation on February 5, 2020.
Feb 5, 2020
Testimony
Implications of U.S.-China Collaborations on Global Health Issues: Addendum
Document submitted on August 19, 2019, as an addendum to testimony before the U.S.-China Economic and Security Review Commission on July 31, 2019.
Aug 20, 2019
Testimony
Implications of U.S.-China Collaborations on Global Health Issues
Testimony presented before the U.S.-China Economic and Security Review Commission on July 31, 2019.
Jul 31, 2019